What is the LAB stock price prediction for next 2 weeks?

According to our price prediction algorithm,Standard BioTools Inc. (LAB) price will be around $0.64 in the next 2 weeks. This means it will decrease by -12.310866574965615 from the last closing price. This prediction may vary from other time period filters for LAB stock.

What can be the highest Possible price of LAB stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, LAB can achieve the highest price of $0.68 which is -5.780363395578273 lower than last closing price. This prediction may vary from other time period filters for LAB stock.

What can be the lowest Possible price of LAB stock in next 2 weeks?

As per the forecast and algorithmic analysis, LAB stock price can be as low as $0.59 which is -18.81649327216665 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for LAB stock.

Will LAB stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that LAB stock will lose-12.310866574965615 in the next 2 weeks. This prediction may vary from other time period filters for LAB stock.

What is LAB stock last closing price?

Last closing price of LAB stock was $0.69.

What is LAB stock price prediction?

LAB stock price prediction means predicting the future closing prices of LAB stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of LAB stock in a certain time period.

How we predict LAB stock future prices?

If you are searching for LAB stock forecast, analysis or price prediction, then you might be wondering what Standard BioTools Inc. (LAB) will do in the future. Our LAB price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This LAB price prediction will likely answer most of your questions.

How frequent we update LAB stock predictions?

We are updating the forecasts for the LAB stock on daily basis.

Is using ML forecasting for LAB stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for LAB stock same for all the time periods?

No, the prediction for LAB stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Standard BioTools Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$0.695.62%Since 2 Weeks

Predicted Price$0.64-12.31%For 2 Weeks

Upper Predicted Price$0.68-5.78%For 2 Weeks

Lower Predicted Price$0.59-18.82%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of LAB will decline by -12.31% over the next 2 Weeks and hit $0.64 by Wednesday, September 23, 2026. In that time frame, LAB's share price is expected to range between $0.59 and $0.68.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Sep 24, 2026	0.62	0.67	0.71
Sep 23, 2026	0.63	0.67	0.72
Sep 22, 2026	0.62	0.67	0.71
Sep 21, 2026	0.62	0.66	0.71
Sep 18, 2026	0.63	0.68	0.72
Sep 17, 2026	0.64	0.69	0.73
Sep 16, 2026	0.65	0.69	0.74
Sep 15, 2026	0.64	0.68	0.73
Sep 14, 2026	0.64	0.68	0.72
Sep 11, 2026	0.65	0.70	0.74

LAB shares fell -5.13% in Thursday, September 10, 2026's trading session, dropping from a previous close of $0.73 to move at $0.69. The stock demonstrated notable intraday movement (see LAB's key stats for a full breakdown), fluctuating between $0.68 and $0.72, a +6.28% trading range. While recent weeks have seen some volatility, LAB has managed to secure a +5.62% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 1.21M shares changing hands, 713.37K fewer than the previous session. This amounted to $835.56K in total market activity.

Will LAB Continue Its Upward Trend?

According to analyst ratings and projections for LAB, Standard BioTools Inc. shares are anticipated to increase by +3.22%, potentially reaching $0.71 per share by September 24, 2026. Short-term technical indicators currently suggest a neutral sentiment for LAB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the LAB stock forecast, now is a good time to buy LAB stock because its current trading price is +3.50% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on LAB covering social and institutional perspectives.

LAB Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into LAB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.14% to 49.32%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.19%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.36%, maintains a neutral outlook for the long term. Insights into LAB's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Standard BioTools Short-Term Forecasts

LAB Forecast For Next 5 Days

Our algorithm anticipates Standard BioTools (LAB) stock could hit $0.60 by Sep 17, 2026. This represents a -13.03% fall from today's price, following a 0 change over the past five days.

LAB Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Standard BioTools Inc. (LAB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.58, which would mean a -15.91% decrease from the current price of $0.69. Projections for this period range from a high of $0.75 to a low of $0.47.

LAB Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Standard BioTools's price over the next three months point to a rise. LAB stock is expected to peak at $5.49 on Sep 15, 2026 before potentially dipping to $4.38 on Oct 22, 2026. On average, LAB is likely to trade around $4.83 in the coming 90 days.

Standard BioTools Stock Forecast 2025

Based on our predictive models, Standard BioTools (LAB) is expected to trade between $4.00 and $5.49 throughout 2026. This would result in an average price of $4.80, potentially offering investors a +595.95% return from current levels.

Standard BioTools Inc. Monthly Forecast 2026–2027

September 2026

According to our latest forecast models, Standard BioTools Inc. (LAB) is positioned to show a strong performance in September 2026. The price is predicted to move between $5.05 and $5.49, settling at an average of $5.31. This could translate to a +669.90% gain.

October 2026

Based on current market signals, Standard BioTools Inc. is projected to trend october 2026. We forecast a trading range from $4.38 to $5.08, with a likely average price of $4.59. Investors could expect a potential return of +565.51%.

November 2026

Our predictive algorithms indicate Standard BioTools Inc. stock may see a shift in November 2026. The expected range spans $4.39–$5.33, with an average target of $4.73. This represents a positive outlook and a possible gain of +585.81%.

December 2026

Analyzing established trends, Standard BioTools Inc. looks set to move in December 2026. Projections place the stock between $4.00 and $5.14, averaging around $4.75. This suggests a +588.71% gain from current levels.

January 2027

Market indicators suggest Standard BioTools Inc. could experience notable changes during January 2027. Prices could fluctuate within $3.16 to $4.75, with a midpoint forecast of $4.38. The stock might deliver a +535.06% gain.

February 2027

Forecasting for February 2027, models estimate that Standard BioTools Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.45 and $3.86, averaging $3.63. This signals a positive trajectory with potential returns around +426.32%.

March 2027

According to our latest forecast models, Standard BioTools Inc. (LAB) is positioned to show a strong performance in March 2027. The price is predicted to move between $1.65 and $3.66, settling at an average of $3.60. This could translate to a +421.97% gain.

April 2027

Based on current market signals, Standard BioTools Inc. is projected to trend april 2027. We forecast a trading range from $0.87 to $3.13, with a likely average price of $3.08. Investors could expect a potential return of +346.57%.

May 2027

Our predictive algorithms indicate Standard BioTools Inc. stock may see a shift in May 2027. The expected range spans $0.23–$2.50, with an average target of $2.75. This represents a positive outlook and a possible gain of +298.72%.

June 2027

Analyzing established trends, Standard BioTools Inc. looks set to move in June 2027. Projections place the stock between $0.00 and $2.48, averaging around $2.27. This suggests a +229.13% gain from current levels.

July 2027

Market indicators suggest Standard BioTools Inc. could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $1.98, with a midpoint forecast of $2.22. The stock might deliver a +221.88% gain.

August 2027

Forecasting for August 2027, models estimate that Standard BioTools Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.81, averaging $2.39. This signals a positive trajectory with potential returns around +246.53%.

September 2027

According to our latest forecast models, Standard BioTools Inc. (LAB) is positioned to show a strong performance in September 2027. The price is predicted to move between $0.00 and $1.74, settling at an average of $2.54. This could translate to a +268.28% gain.

LAB's history of dividends and stock splits also plays a role in long-term investor confidence.